Innovator IBD 50 ETF (NYSEARCA:FFTY) Stock Price Up 1.9% – Time to Buy?

Innovator IBD 50 ETF (NYSEARCA:FFTY)’s stock price traded up 1.9% during trading on Monday . The company traded as high as $28.41 and last traded at $28.34. 91,472 shares were traded during mid-day trading, a decline of 21% from the average session volume of 115,649 shares. The stock had previously closed at $27.81.

Innovator IBD 50 ETF Stock Down 2.0 %

The firm has a 50 day moving average of $29.60 and a 200 day moving average of $28.99. The firm has a market cap of $66.53 million, a PE ratio of 33.68 and a beta of 1.24.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Raymond James Financial Inc. bought a new stake in Innovator IBD 50 ETF in the 4th quarter valued at about $284,000. Tower Research Capital LLC TRC increased its stake in shares of Innovator IBD 50 ETF by 47.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 15,225 shares of the company’s stock worth $435,000 after purchasing an additional 4,883 shares in the last quarter. Comprehensive Financial Planning Inc. PA bought a new stake in shares of Innovator IBD 50 ETF in the fourth quarter valued at approximately $437,000. Two Sigma Investments LP purchased a new stake in shares of Innovator IBD 50 ETF during the 4th quarter valued at approximately $1,138,000. Finally, Jane Street Group LLC boosted its holdings in Innovator IBD 50 ETF by 51.5% in the 3rd quarter. Jane Street Group LLC now owns 49,781 shares of the company’s stock worth $1,339,000 after buying an additional 16,912 shares during the period.

About Innovator IBD 50 ETF

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.